Introduction
After respiratory tract infections, urinary tract infections (UTI) are the second most common community-acquired infections that lead to health care visits in the United States (Schappert & Rechtsteiner, 2011) . Also hospital-acquired UTIs comprise as much as 36% of nosocomial infections in the U.S. (Klevens et al., 2007) , and about 9-31% of sepsis cases originate from urinary tract infections (Levy et al., 2012) . Urosepsis risk is increased in persons who are elderly, immunocompromised, diabetic, pregnant, or carry structural urinary tract abnormalities. Urosepsis may lead to severe sepsis and septic shock and its mortality rate is around 5% (Foxman, 2014) . Of patients with acute pyelonephritis, only about 20-30% show positive blood cultures (Sandberg et al., 2012) , and thus the definitive diagnosis for the rest of the pyelonephritis patients relies on the urine culture.
Most often UTI are caused by one bacterial species: in about 80% of cases the causative agent is Escherichia coli. In typical laboratory UTI diagnostics, the pathogen is identified in 24 h, and the antibiotic susceptibility testing (AST) results become available in 48 h. First, the patients are treated empirically, and the antibiotic will be changed according to the susceptibility results when necessary.
Several rapid diagnostic methods for identification of pathogens in urine samples have been introduced recently (Ferreira et al., 2010 (Ferreira et al., , 2011 Köhling et al., 2012; Burillo et al., 2014; DeMarco and Burnham, 2014; Kim et al., 2015; Veron et al., 2015; Íñigo et al., 2016) . However, all these methods include laborious pre-handling, e.g. centrifugation or filtration steps, to get rid of other urine components, before MALDI-TOF MS analysis. This is problematic for many clinical laboratories that analyze hundreds of specimens daily. Minimal hands-on time is thus appreciated and essential to implement a new method for daily routine.
A rapid method for identification of bacteria from positive blood culture bottles, called si-MALDI-TOF MS (short incubation matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) has recently been introduced (Bhatti et al., 2014; Kalanti et al., 2014; Kohlmann et al., 2015; Zabbe et al., 2015) . In this method a few drops of blood from a positive blood culture bottle were incubated for a short time (3-4 h) on a conventional chocolate agar and subjected to MALDI-TOF MS even without visible colonies. By this method, Gramnegative bacteria were correctly identified in 87% and Gram-positive bacteria in 69% of the samples tested. E. coli was correctly identified in 91.5% of the samples (Kalanti et al., 2014) .
Based on these results regarding blood cultures, we tested whether a 3-h si-MALDI-TOF method could be useful for typically acquired clinical urine samples to reduce the turnaround time for the pathogen identification.
Materials and methods

Clinical samples
The urine samples ( 
Conventional urine culture
Urine was inoculated onto BD™ CHROMagar™ Orientation (Becton Dickinson and Company) plate using a 1 μl calibrated loop (Berner Pro, Helsinki, Finland) and incubated at 35°C in ambient air for 18 h according to our standard urine culture protocol. One or two significant UTI pathogens were identified by routine MALDI-TOF MS (bioMérieux, Marcy l'Etoile, France) from individual colonies. E. coli was identified either by the color reaction on CHROMagar or by routine MALDI-TOF MS. When three or more organisms were observed, the result was interpreted as mixed flora. The amount of bacteria (cfu/ml) was derived by counting colonies on the CHROMagar plate, N10-100 colonies inoculated with a 1 μl loop representing 10 4 -10 5 cfu/ml in the urine sample, and N 100 colonies representing N10 5 cfu/ml.
Sample preparation for U-si-MALDI-TOF and routine MALDI-TOF analysis
The samples were mixed by inverting the tubes a few times, and 200 μl of urine was pipetted on chocolate agar plate as a spot. Two spots per sample were performed. The plates were incubated at 35°C with 5% CO 2 for 3 h. After incubation, a sample from the spot area with visible or invisible growth was taken with a 1 μl loop to the MALDI-TOF target plate. The spot was subjected to routine MALDI-TOF MS with 1 μl of α-cyano-4-hydroxycinnamic acid (CHCA) matrix and air-drying at room temperature. MALDI-TOF MS measurements were performed on VITEK MS mass spectrometer (bioMérieux) and analyzed against the IVD database by MYLA Software (bioMérieux). The VITEK MS IVD database consists of ca. 750 clinically relevant species with an average of N 14 isolates/species and 36 mass spectra/species. The results appear as percentages, 99.9% being the highest value. The identification was accepted when ≥97.5% identification was detected in at least one of the duplicate spots, and when the species identified was a potential uropathogen. However, if the results were discordant in the duplicate spots (two different species), or if the identification resulted in species that does not grow on CHROMagar or on chocolate agar or was not a uropathogen, the sample was regarded as negative.
Results
Two hundred seven screening test positive urine samples were analyzed in parallel with U-si-MALDI-TOF and conventional culture. In conventional urine culture, 16 samples were negative, 49 samples grew mixed flora, and 142 samples showed significant growth (N10 5 or 10 4-5 cfu/ml) of one colony morphology. Compared to conventional urine culture, the overall sensitivity of U-si-MALDI-TOF was 67% and specificity 79% for the detection of uropathogens. Positive predictive value of the test was 87% and negative predictive value 55%.
Of the 142 samples showing significant growth, E. coli N 10 5 cfu/ml represented the majority (87/142), and U-si-MALDI-TOF successfully identified 75 (86%) of them (Table 2) . Of the rest of the samples with E. coli N 10 5 cfu/ml, 11 (13%) were negative with U-si-MALDI-TOF, and one gave a U-si-MALDI-TOF result of Citrobacter sp. instead of E. coli. This E. coli was identified in conventional culture by the red color reaction on CHROMagar, not by MALDI-TOF MS. Only one (14%) sample with 10 4-5 cfu/ml of E. coli was correctly identified by U-si-MALDI-TOF, and the rest consisting of six samples (86%) gave negative results. Unspecific recognition with poor identification percentage or bacteria of the normal microbiota of the urogenital tract (Lactobacillus sp., Gardnerella vaginalis, Bacillus badius, Clostridium ramosum) were Table 2 Accuracy of U-si-MALDI-TOF for identification of Gram-negative bacteria.
Culture result cfu/ml n U-si-MALDI-TOF correct identification n (%) identified in one of the duplicate spots in four samples. These were interpreted as negative.
In 20 samples, a Gram-negative rod other than E. coli (N10 5 cfu/ml) was identified by conventional culture. Of those, 17 (85%) were correctly identified by U-si-MALDI-TOF. K. pneumoniae was successfully identified in 7/7 (100%) samples. One Klebsiella oxytoca was incorrectly identified as Proteus sp. by U-si-MALDI-TOF. Furthermore, one Enterobacter sp. and one Morganella morganii gave negative results by U-si-MALDI-TOF. U-si-MALDI-TOF did not perform as well in samples with Gram-positive bacteria (growth N10 5 or 10 4-5 cfu/ml). From 28 conventional cultures that generated Gram-positive growth, 14 were identified as Enterococcus faecalis by routine MALDI-TOF MS; only one of these was correctly identified using U-si-MALDI-TOF assay. All other samples analyzed by U-si-MALDI-TOF gave a false negative result (Table 3) . The conventional culture resulted in mixed flora in 49/207 samples, most of which represented voided midstream urine samples. Of the mixed flora samples, 37 (67%), were regarded as negative in U-si-MALDI-TOF assay. Of those, 27 samples gave no result, and 10 samples showed unspecific recognition with "impossible" result, discordant result in duplicate spots and/or poor identification percentage, or species that was not a uropathogen. E. coli was detected in six samples, and other Gram-negative rods in six samples (Enterobacter aerogenes, Morganella morganii, Proteus vulgaris/penneri, Serratia marcescens, and two Klebsiella pneumoniae) by U-si-MALDI-TOF in both duplicate spots in the mixed flora samples. All culture negative samples (16/207) were negative also in U-si-MALDI-TOF analysis.
Discussion
Using U-si-MALDI-TOF we were able to correctly identify 86% (92/ 107) of the Gram-negative urinary pathogens in samples with bacterial load of N10 5 cfu/ml. Our results suggest that short incubation combined with MALDI-TOF MS might be useful for the identification of Gram-negative urinary pathogens, in particular E. coli, when urine bacterial count is N10 5 cfu/ml. This is in line with previous findings regarding similar methods (Ferreira et al., 2010 (Ferreira et al., , 2011 DeMarco and Burnham, 2014; Veron et al., 2015) . We propose that this method can be used in attempting to diagnose patients with suspected pyelonephritis and urosepsis when rapid diagnosis is invaluable and the amount of bacteria in urine is usually high; however, further evaluation is needed for samples of patients with these diagnoses. Under certain clinical situations, such as samples of the pyelostomy or paracentesis of the urinary bladder, a cfu/ml value less than 10 5 could be significant, and in these cases, conventional urine culture would be recommended instead of U-si-MALDI-TOF analysis. The conventional urine culture, in which the bacteria are identified on the basis of the color reaction on chromogenic agar or with MALDI-TOF MS, requires an overnight incubation. The final result with antibiotic susceptibility is usually available after 48 h. The use of various tests, such as nitrite, leukocyte, and/or bacterial count and Gram staining have been assessed for rapid identification of bacteria from urine samples (Ferreira et al., 2010; Burillo et al., 2014; Veron et al., 2015) .
However, the sensitivity, specificity, and hands-on time of these tests varies. Using U-si-MALDI-TOF we were able to shorten the turnaround time of the identification process of Gram-negative urinary pathogens from 24 h to 4-6 h.
In complicated UTI it is critical to know the causative pathogen to be able to change the empirical antibiotic treatment accordingly. This is important when, e.g. P. aeruginosa or another AmpC-producing species, such as Enterobacter cloacae, Citrobacter sp., or M. morganii, is involved. Unfortunately we only had one P. aeruginosa sample in our study, anyhow it was correctly identified. Overall, the amount of Gram-negative rods other than E. coli was rather small in our analysis, and this needs further investigation.
The si-MALDI-TOF of positive blood cultures correctly identifies 87% of Gram-negative bacteria and 69% of Gram-positive bacteria (Kalanti et al., 2014) . Notably, the bacterial amount in a positive blood culture bottle is higher (10 6 -10 9 cfu/ml) compared with the bacterial load in a typical urine sample (10 3 -10 6 cfu/ml). This may be the reason why Grampositive bacteria failed to be identified using U-si-MALDI-TOF. Use of collection tubes with preservative agents may alter the amount of Gram-positive bacteria more than that of Gram-negative bacteria. The use of MALDI-TOF MS for direct identification of urinary tract pathogens has been evaluated by few studies, but typically these methods require various sample preparation protocols, such as centrifugation or filtration steps (Ferreira et al., 2010 (Ferreira et al., , 2011 Köhling et al., 2012; Burillo et al., 2014; DeMarco and Burnham, 2014; Kim et al., 2015; Veron et al., 2015; Íñigo et al., 2016) . Our method is able to avoid laborious pre-handling steps maybe because the components that disturb the MS analysis are either absorbed into the solid medium or lysed during the incubation. The advantages of this method are its rapidness, easiness, and minimal hands-on time. The only significant cost is the purchase of MALDI-TOF mass spectrometer, which is however already routinely used in many clinical laboratories in the Western countries nowadays.
U-si-MALDI-TOF would complement the diagnostics of urosepsis, especially when combined with rapid AST. Rapid AST made directly from the urine sample by disk diffusion would reduce the turnaround time with several hours to b 24 h, and this has actually been tested by Enterobacteriaceae with good results (Sundqvist et al., 2015) . Also other methods, such as isothermal microcalorimetry (Braissant et al., 2014) and 16S rRNA based method (Mezger et al., 2015) have been successfully applied for rapid AST from the urine samples. Combining rapid identification with rapid AST could improve the treatment results of urosepsis patients and even reduce the time and costs of hospital stays.
Conclusions
U-si-MALDI-TOF MS is a reliable rapid method for the identification of the Gram-negative bacteria, the most common causative agents of UTI and urosepsis. In the future, the method could be incorporated to the diagnostic work-up of pyelonephritis and sepsis when rapid identification of urinary pathogens is needed. Combined with rapid AST, it could significantly advance the diagnostics of UTI and reduce related morbidity and mortality. 
